About Seoul Biomedical International Conference
Seoul Biomedical International Conference 2019 marked its success, following the 2016, 2017, 2018 conferences. Here is the breakdown on Seoul Biomedical International Conference 2019 held on November 4, 2019 at the Seoul City Hall. In the Session 3 of the event, Joseph (Joe) P. McMenamin, an Executive Vice President and Chief Legal Officer with W Medical Strategy Group, delivered a speech crucial to the industry.
Conference’s Objective
Presenting global strategies and case studies from the early stage to exit for biomedical startups
Providing a platform for a global network and attracting investment
Providing opportunities for open innovation cooperation by inviting global leaders of bio-innovation
November 4, 2019
10:00 AM – 16:45 PM (GMT +9)
Conference Hall (8F), Seoul City Hall
Program
10:00-10:15 AM Opening Ceremony
10:15-11:15 AM Keynote Speech
Cost-Effective Drug Discovery and Development
Brian Seed, Professor, Harvard Medical School & Massachusetts General Hospital
Successful Technology Commercialization at Marshall University- It's a Team Sport
John Maher, Vice President for Research, Marshall University
The Role of the Regulatory Agency in Promoting Innovation in Drug Development
Zili Li, AP R&D Head of Janssen, Johnson & Johnson
11:15-12:15 PM Session 1. Lab to Startup Building
Seoung-Yong Seong (Moderator), Professor, Seoul National University College of Medicine
Collaboration of Lab to Start-Up: KRICT Case
Hyuk Lee, Director of Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology
Building a Successful Korean/U.S. Hybrid Biotech Startup
Seulki Lee, Professor, Johns Hopkins School of Medicine
Discussion
12:15-13:40 PM Networking Luncheon
2:15-3:15 PM Session 2. Incubating & Accelerating
Andy Jang (Moderator), CEO, Starssets Investment
Turning Innovations in Genomics into Successful Business – a VC Perspective
Wouter Meuleman, Principal, illumine Ventures
Accelerating Innovation through Innovative Partnerships with Leading Academic Institutions and Strategic Partners
Carl S. Goldfischer, President, Forge Bioscience
Catalyzing Innovation to Deliver Transformational Solutions
Sharon Chan, Head JLABS @Shanghai, Johnson & Johnson
Discussion
3:00-3:20 PM Coffee Break
3:20-4:40 PM Session 3. Business Development
Hyunsang Muk (Moderator), President & CEO, Korea Drug Development Fund
Reward is a Function of Risk: Entering the American Market
Joseph McMenamin, EVP and GC, W Medical Strategy Group
Key Lessons on How to Negotiate a Successful Deal
Fintan Walton, Founder and CEO, Pharma Ventures
Open Innovation Strategy to Build Global Opportunity
Sang Hoon Lee, CEO, ABL BIO
Discussion
4:40-4:45 PM Closing
